Vaccine News and Research

Latest Vaccine News and Research

Study analyzes how four types of COVID-19 vaccines prepare the body to fight SARS-CoV-2

Study analyzes how four types of COVID-19 vaccines prepare the body to fight SARS-CoV-2

Evidence on COVID-19 vaccine effectiveness and duration of protection against Omicron

Evidence on COVID-19 vaccine effectiveness and duration of protection against Omicron

The effectiveness of tixagevimab/cilgavimab for prevention of SARS-CoV-2 infection and severe disease among immunocompromised patients

The effectiveness of tixagevimab/cilgavimab for prevention of SARS-CoV-2 infection and severe disease among immunocompromised patients

The effect of CMV serostatus on humoral and cellular measures of vaccine responses after 2 and 3 doses of SARS-CoV-2 mRNA vaccines in older adults

The effect of CMV serostatus on humoral and cellular measures of vaccine responses after 2 and 3 doses of SARS-CoV-2 mRNA vaccines in older adults

Study evaluates protection conferred by prior infection and vaccination against the SARS-CoV-2 Omicron variant within the California state prison system

Study evaluates protection conferred by prior infection and vaccination against the SARS-CoV-2 Omicron variant within the California state prison system

Politics and pandemic fatigue doom California’s covid vaccine mandates

Politics and pandemic fatigue doom California’s covid vaccine mandates

HIV research enables knowledge transfer for improved COVID-19 response

HIV research enables knowledge transfer for improved COVID-19 response

New Director of Science, Research and Evidence will help steer research across health and social care

New Director of Science, Research and Evidence will help steer research across health and social care

Evaluating tixagevimab plus cilgavimab against SARS-CoV-2

Evaluating tixagevimab plus cilgavimab against SARS-CoV-2

Prevalence of SARS-CoV-2 infection during Omicron BA.2/BA.2.12.1 surge in New York

Prevalence of SARS-CoV-2 infection during Omicron BA.2/BA.2.12.1 surge in New York

Study investigates whether people with breakthrough SARS-CoV-2 infection develop post-acute sequelae

Study investigates whether people with breakthrough SARS-CoV-2 infection develop post-acute sequelae

Sarbecovirus open reading frame 7a suppresses major histocompatibility complex-I antigen presentation

Sarbecovirus open reading frame 7a suppresses major histocompatibility complex-I antigen presentation

Researchers identify a human monoclonal antibody that could broadly neutralize several variants of SARS-CoV-2, SARS-CoV, and other coronaviruses

Researchers identify a human monoclonal antibody that could broadly neutralize several variants of SARS-CoV-2, SARS-CoV, and other coronaviruses

Method for predicting neutralization and protection based on variant-specific antibody measurements to SARS-CoV-2 antigens

Method for predicting neutralization and protection based on variant-specific antibody measurements to SARS-CoV-2 antigens

Study evaluates waning levels of protection against SARS-CoV-2 infection among recovered persons and uninfected BNT162b2 vaccinees

Study evaluates waning levels of protection against SARS-CoV-2 infection among recovered persons and uninfected BNT162b2 vaccinees

Direct comparison of immune memory responses to four COVID-19 vaccines

Direct comparison of immune memory responses to four COVID-19 vaccines

Hemodialysis patients obtain a robust humoral response from a third dose of the BNT162b2 vaccine, study finds

Hemodialysis patients obtain a robust humoral response from a third dose of the BNT162b2 vaccine, study finds

Mapping the Types and Traits of Immune Cells

Mapping the Types and Traits of Immune Cells

Public health communication may be highly effective when an 'autonomy-supportive' approach is used

Public health communication may be highly effective when an 'autonomy-supportive' approach is used

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.